ArticleACS infectious diseases2026
Random Forest Modeling to Predict Small Molecule Accumulation in Gram-Negative Bacteria.
Article in ACS infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Despite extensive efforts over the past ∼60 years to discover new classes of Gram-negative-active antibiotics, the development pipeline remains relatively dry. These failures can be largely ascribed to the complexity of the Gram-negative membranes and an inadequate understanding of physicochemical properties associated with compound permeation, efflux evasion, and overall accumulation in Gram-negative pathogens. Recent work using unbiased accumulation assays and advanced chemical descriptors has utilized machine learning algorithms, particularly random forest modeling, to correlate physicochemical properties of small molecules with accumulation. The ability of a random forest classifier to effectively process large data sets while still providing human-interpretable insight makes this model a valuable tool in accumulation data analysis. Here, we describe in detail a workflow reliant on random forest modeling to probe physicochemical trends linked to small molecule permeation and/or efflux liabilities in Gram-negative pathogens. Applications using random forest modeling have led to guidelines for small molecule accumulation in E. coli and P. aeruginosa that have resulted in multiple new Gram-negative-active antibiotics. Random forest modeling possesses several distinct advantages over other machine learning models for the purposes of identifying physicochemical trends in accumulation, and as such, provides valuable hypothesis-generating information for the study of small molecule accumulation in Gram-negative bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.